By Saqib Iqbal Ahmed NEW YORK (Reuters) -The dollar slipped against most major currencies on Wednesday after July U.S. job openings data signaled a softening labor market, tilting the odds further in favor of larger interest rate cuts by the Federal Reserve. Traders boosted bets that the Fed will deliver a half-a-percentage-point reduction at its…
By Kenrick Cai, Krystal Hu, Anna Tong SAN FRANCISCO/NEW YORK -Safe Superintelligence (SSI), newly co-founded by OpenAI’s former chief scientist Ilya Sutskever, has raised $1 billion in cash to help develop safe artificial intelligence systems that far surpass human capabilities, company executives told Reuters. SSI, which currently has 10 employees, plans to use the funds…
By Ricardo Brito and Luciana Magalhaes BRASILIA/SAO PAULO (Reuters) -Tensions between Brazil and Elon Musk’s business empire ratcheted up further as the country’s telecoms regulator threatened to sanction his satellite broadband company Starlink hours after its top court stood behind a controversial decision to ban social network X from the country. Brazil’s President Luiz Inacio Lula da…
SAO PAULO (Reuters) – Brazilian President Luiz Inacio Lula da Silva said on Friday that billionaire Elon Musk must respect the rulings of the country’s Supreme Court, amid an ongoing feud that left social media giant X on the brink of being taken down in Brazil. X was still working normally in Brazil on Friday…
(Reuters) -The U.S. Food and Drug Administration granted expanded approval to Emergent BioSolutions’ smallpox vaccine for use by people at high risk of mpox infection, sending the drugmaker’s shares surging 20% before the bell on Friday. The FDA clearance, announced late Thursday by the company, makes the vaccine, called ACAM2000, the second approved shot against…
By Johann M Cherian and Noel Randewich (Reuters) -U.S. stocks fell on Wednesday ahead of a quarterly report from Nvidia, Wall Street’s centerpiece event of the week that could shatter or add fresh fuel to a rally driven by optimism around artificial intelligence. Shares of the dominant seller of AI processors, due to report after…
By Patrick Wingrove (Reuters) -Eli Lilly said it has begun selling vials of the smallest, starter dose of its popular weight-loss drug Zepbound in the United States for $399 for a month on its direct-to-consumer website to try to increase supplies in the marketplace. Zepbound is typically sold in auto-injector pens, but with vials Lilly…
By Max A. Cherney SAN FRANCISCO (Reuters) – The sudden resignation of a high-profile Intel board member came after differences with CEO Pat Gelsinger and other directors over what the director considered the U.S. company’s bloated workforce, risk-averse culture and lagging artificial intelligence strategy, according to three sources familiar with the matter. Lip-Bu Tan, a…
By Saqib Iqbal Ahmed NEW YORK (Reuters) – Traders in the U.S. equity options market are expecting Nvidia’s upcoming earnings report to spark a more than $300 billion swing in the shares of the world’s most dominant artificial intelligence chipmaker. Options pricing shows that traders anticipate a move of around 9.8% in the company’s shares…
By Svea Herbst-Bayliss NEW YORK (Reuters) -Elliott Investment Management, which now holds voting power over roughly 9.7% of Southwest Airlines, is telling investors the company needs new outside leadership for a “better future,” but it is also ready to press ahead with a planned proxy fight. In a letter to shareholders, the hedge fund is…
